⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 46 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 46 minutes ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT August 13, 2026

Spevigo 150 mg Injektionslösung in einer Fertigspritze 150 mg (Injektionslösung in einer Fertigspritze)

📷 EU Safety Watch placeholder
Spevigo 150 mg Injektionslösung in einer Fertigspritze 150 mg (Injektionslösung in einer Fertigspritze)
📷 EU Safety Watch placeholder
Spevigo 150 mg injection solution in a pre-filled syringe 150 mg (injection solution in a pre-filled syringe) is subject to a parallel export ban. Supply is restricted due to manufacturing delays.
⚠️
Shortage ongoing
SPESOLIMAB is currently in short supply in AT.
📈 Timeline
28 days active so far
August 15, 2026 September 11, 2026

What is this? Spevigo is a medicine given as an injection. It helps treat certain skin problems.

What's happening? There is a short supply of Spevigo. This is because making it is taking longer than usual.

Does this affect me? If you use Spevigo, you may have trouble getting it. This notice is for Austria.

What should I do? Talk to your pharmacist or doctor before making any changes to your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
SPESOLIMAB
Agency-published detail

🚫 Parallel export ban active · ATC: L04AC22 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: LEO PHARMA A/S, Industriparken 55, 2750 Ballerup, Kingdom of Denmark · Affected packs: 2 Stück Schachtel, Fertigspritze [eingeschränkt verfügbar, since 2026-08-13, resupply 2026-12-01]

First published
August 13, 2026
Last refreshed by us
18 hours ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Spevigo 150 mg Injektionslösung in einer Fertigspritze 150 mg (Injektionslösung in einer Fertigspritze). Spevigo 150 mg injection solution in a pre-filled syringe 150 mg (injection solution in a pre-filled syringe) is subject to a parallel export ban. Supply is restricted due to manufacturing delays.
▸ When was this alert issued?
This alert was issued on August 13, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.